公司董事会收到董事邓明辉先生的书面辞职报告，因退休原因，邓明辉先生辞去公司第 九届董事会董事及审计与风险管理委员会委员职务，辞职后邓明辉先生将不在公司担任任何 职务 证券代码：600315 证券简称：上海家化 公告编号：2025-052 上海家化联合股份有限公司 关于公司董事离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 根据《公司法》、《公司章程》等相关规定，邓明辉先生离任不会导致董事会 成员低于法定人数，不会影响董事会正常运作，辞职报告自送达董事会之日起生 效。公司将按照法定程序补选董事。 邓明辉先生不存在未履行完毕的公开承诺并且已按照相关规定做好交接工 作。公司及公司董事会对邓明辉先生在任职期间为公司发展做出的贡献表示衷心 感谢！ 特此公告。 上海家化联合股份有限公司董事会 2025 年 11 月 1 日 一、董事/高级管理人员离任情况 (一) 提前离任的基本情况 | | 离任职务 | 离任时间 | 原定任期到 期日 | | 是否继续在上市 | 具体职务 | 是否存在未 | | --- | - ...

Group 1 - The company announced that board member Deng Minghui has submitted a written resignation due to retirement [1] - Deng Minghui will no longer hold any position within the company after his resignation [1] - The resignation is effective immediately upon delivery to the board [1]

Core Insights - The company Shanghai Jahwa has shown significant growth in revenue and net profit for the first three quarters of 2025, with a revenue of 4.96 billion and a net profit of 405 million, marking increases of 10.8% and 149.1% year-on-year respectively [2][3][6] - The company is focusing on its core brands and has seen substantial growth in its beauty segment, with a 272.3% increase in all-channel sales [3][4] - New product launches, particularly in the beauty category, have driven sales, with notable successes such as the "Xian Cao Oil" and "Bee Propolis Fragrance Hand Cream" [5][12] Financial Performance - For the first nine months of 2025, the company achieved an operating income of 4.96 billion, a 10.8% increase from the previous year, and a net profit of 405 million, up 149.1% [2][3] - The operating cash flow increased by 172.8% year-on-year, indicating improved financial health [2] - In Q3 alone, revenue grew by 28.3% year-on-year, with net profit reaching 139 million [2][3] Business Strategy - The company is implementing a "four focuses" strategy, concentrating on core brands, segmented markets, and major products [3][7] - There is a strong emphasis on online sales channels, with significant growth in e-commerce operations and marketing investments [6][9] - The company plans to enhance brand marketing efforts in alignment with revenue growth, particularly during major sales events like "Double Eleven" [8][10] Product Development - The introduction of new products has been a key driver of growth, with successful launches such as the "Xian Cao Oil" and "Bee Propolis Fragrance Hand Cream" [5][12] - The company aims to continue focusing on high-concentration, natural ingredient products, which resonate well with current market trends [5][12] - The marketing strategy includes leveraging celebrity endorsements to enhance brand visibility and consumer engagement [12][13] Market Positioning - The beauty segment has shown remarkable growth, particularly in online channels, with a 173.3% increase in domestic online sales [3][4] - The company is actively working to improve its overseas business, which has faced challenges but is expected to recover through strategic focus on core categories and online sales [3][4] - The brand's positioning is reinforced through targeted marketing and product innovation, aiming to capture a larger market share in the beauty and personal care industry [4][5]

Core Viewpoint - Fulejia, a well-known company in the professional skin care sector, was established on November 28, 2017, and went public on August 1, 2023, in Shenzhen. The company has a strong market position due to its high-quality products and robust R&D capabilities [1]. Group 1: Business Performance - In Q3 2025, Fulejia reported revenue of 1.297 billion yuan, ranking 7th among 8 companies in the industry. The top company, Proya, had revenue of 7.098 billion yuan, while the industry average was 3.238 billion yuan [2]. - The main business composition showed that cosmetic revenue was 625 million yuan, accounting for 72.39%, while medical device revenue was 238 million yuan, making up 27.61% [2]. - The net profit for the same period was 325 million yuan, ranking 3rd in the industry, with Proya leading at 1.055 billion yuan and the industry average at 329 million yuan [2]. Group 2: Financial Health - Fulejia's debt-to-asset ratio was 3.60% in Q3 2025, slightly down from 3.62% the previous year, significantly lower than the industry average of 25.15%, indicating strong solvency and low financial risk [3]. - The gross profit margin was 81.11%, slightly down from 81.65% year-on-year, but still above the industry average of 66.60%, reflecting strong profitability [3]. Group 3: Management and Shareholder Information - Chairman Zhang Liguan's salary for 2024 was 619,400 yuan, a decrease of 3,000 yuan from 2023. The general manager, Sun Na, had a salary of 1.8298 million yuan, down 37,000 yuan from the previous year [4]. - As of September 30, 2025, the number of A-share shareholders decreased by 1.29% to 14,800, with an average holding of 5,229.49 shares, an increase of 1.22% [5]. Group 4: Market Trends and Future Outlook - According to Changjiang Securities, Fulejia's cosmetic segment showed steady growth in H1 2025, with revenues of 620 million yuan, a year-on-year increase of 29.95%, while medical device revenue saw a decline of 48% [6]. - The online sales channel performed exceptionally well, with online revenue reaching 690 million yuan, a 47% increase year-on-year, while offline sales dropped by 64% [6]. - The company is expected to see earnings per share (EPS) of 1.04, 1.16, and 1.28 yuan for 2025 to 2027, maintaining a "buy" rating [6].

Core Viewpoint - Lafang Jiahua is a leading domestic brand in the washing and hair care industry, with a focus on product development, production, and sales across various beauty segments, including hair care, skin care, and cosmetics [1] Group 1: Business Performance - In Q3 2025, Lafang Jiahua reported revenue of 627 million yuan, ranking 8th among 8 companies in the industry, with the industry leader, Proya, generating 7.098 billion yuan [2] - The main business revenue composition includes hair care at 778 million yuan (87.57%), other income at 84.56 million yuan (9.52%), soap at 25.22 million yuan (2.84%), and other supplementary income at 716,700 yuan (0.08%) [2] - The net profit for the same period was 12.71 million yuan, also ranking 8th in the industry, with Proya leading at 1.055 billion yuan [2] Group 2: Financial Ratios - As of Q3 2025, Lafang Jiahua's debt-to-asset ratio was 11.38%, a slight decrease from 11.54% year-on-year, significantly lower than the industry average of 25.15%, indicating strong solvency [3] - The gross profit margin for the period was 48.49%, an increase from 47.39% year-on-year, but still below the industry average of 66.60%, suggesting room for improvement in profitability [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 11.38% to 18,400, with an average holding of 12,300 circulating A-shares, a decrease of 10.22% [5] - The top ten circulating shareholders include Huaxia Domestic Demand Driven Mixed A (011278), which is a new shareholder holding 985,800 shares [5] Group 4: Future Outlook - Analysts predict that Lafang Jiahua will see significant revenue growth, with forecasts of 984 million yuan, 1.094 billion yuan, and 1.240 billion yuan for 2025-2027, respectively, alongside an EPS of 0.29, 0.33, and 0.35 yuan [5] - The company is expected to enhance its marketing efforts, particularly on platforms like Douyin, and is exploring opportunities in the medical beauty sector [6] - Forecasted net profits for 2025-2027 are 72 million yuan, 92 million yuan, and 115 million yuan, reflecting substantial year-on-year growth [6]

Core Viewpoint - The cosmetics sector experienced a decline of 2.02% on October 30, with Shuiyang Co. leading the drop. The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1]. Group 1: Market Performance - The cosmetics sector saw a significant drop, with Shuiyang Co. falling by 10.25% to a closing price of 19.87 [2]. - Other notable declines included Qing Song Co. at -3.38%, Beitaini at -2.79%, and Shanghai Jahwa at -2.67% [2]. - The overall trading volume for the cosmetics sector was substantial, with Shuiyang Co. alone accounting for a trading volume of 399,500 shares and a transaction value of 817 million [2]. Group 2: Capital Flow - The cosmetics sector experienced a net outflow of 111 million from main funds, while retail investors saw a net inflow of 39.41 million [2]. - The main funds showed varying levels of inflow and outflow across different companies, with Qingdao Jinwang receiving a net inflow of 53.98 million, while LaFang Home Care faced a net outflow of 7.27 million [3]. - The overall sentiment in the sector indicates a cautious approach from institutional investors, contrasting with the slight interest from retail investors [2][3].

Investment Rating - The investment rating for the company is "Outperform the Market" [5][3][21] Core Views - The company's revenue showed steady growth, with a year-on-year increase of 21% in Q3, and a net profit turnaround, achieving a net profit of 0.13 billion, compared to a loss in the same period last year [1][2] - The high-end brand transformation strategy is proving effective, with strong performance from brands like Ifidan and PA, and a positive outlook for long-term growth as the company continues to develop its high-end brand matrix [3][5] - Despite some pressure on net profit margins due to one-time expenses, the overall financial health remains strong, with improvements in gross and net profit margins [2][3] Revenue and Profitability - For the first three quarters, the company achieved revenue of 34.09 billion, a year-on-year increase of 11.96%, and a net profit of 1.36 billion, up 44.01% [1] - In Q3 alone, revenue reached 9.09 billion, marking a 20.92% increase year-on-year, with a net profit of 0.13 billion, indicating a successful recovery [1][2] Financial Metrics - The company's gross margin and net margin for Q3 2025 were 69.82% and 1.38%, respectively, showing year-on-year improvements of 1.83 and 2.87 percentage points [2] - The forecast for net profit for 2025-2027 has been adjusted to 1.76 billion, 2.71 billion, and 3.21 billion, respectively, reflecting the impact of one-time management expenses and initial marketing investments for new brands [3][4] Operational Efficiency - Inventory turnover days decreased by 7 days to 200 days, and accounts receivable turnover days also improved by 7 days to 31 days, indicating enhanced operational efficiency [2][4] - The company reported a positive operating cash flow of 0.23 billion in Q3 2025, marking a turnaround from previous losses [2]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Insights - The company reported a significant increase in revenue and net profit for Q3 2025, with revenue reaching 1.483 billion yuan (up 28.3% year-on-year) and net profit of 140 million yuan (up 285.4%) [7] - The beauty segment showed rapid revenue growth, with the personal care segment generating 606 million yuan (up 13.8%), and the beauty segment achieving 354 million yuan (up 272.3%) [7] - The company is focusing on four strategic adjustments to enhance profitability and is optimistic about the improvement in operational quality leading to better performance [7] Financial Performance Summary - For 2023A, the company reported revenue of 6,598 million yuan, with a revenue growth rate of -7.2% [6] - The forecast for 2025E indicates revenue of 6,276 million yuan, with a projected net profit of 407 million yuan and an EPS of 0.60 yuan [6][8] - The company's gross margin for Q3 2025 was 61.5%, reflecting a 7.0 percentage point increase [7] Strategic Focus - The company is enhancing its core products and expanding its online channel presence, launching key products such as Bai Cao Ji Xian Cao Oil and Meijiajing Propolis Repair Cream [7] - The dual-channel strategy of "online + offline" is being leveraged to drive growth, supported by brand marketing and influencer investments [7] Earnings Forecast - The company is expected to achieve net profits of 4.07 billion yuan, 4.81 billion yuan, and 5.98 billion yuan for the years 2025, 2026, and 2027 respectively, with corresponding PE ratios of 42.1, 35.6, and 28.6 [7]

Core Insights - A total of 295 stocks received buy ratings from institutions today, with notable upgrades for Shanghai Jahwa, Shuangliang Energy, and Crystal Optoelectronics, while 7 stocks received initial attention from institutions [1][2] Group 1: Institutional Ratings - 432 buy rating records were published today, with Chengdu Bank receiving the highest attention at 8 buy ratings [1] - Among the stocks rated, 149 provided future target prices, with 5 stocks showing an upside potential exceeding 50%, led by Haise Science with a target price of 92.88 yuan, indicating an upside of 82.87% [1] - 7 stocks received initial attention from institutions, including Daotong Technology and Keri Technology [1] - 3 stocks had their ratings upgraded, including Shanghai Jahwa and Shuangliang Energy [1] Group 2: Market Performance - Stocks with buy ratings averaged a gain of 1.23%, outperforming the Shanghai Composite Index [1] - 189 stocks saw price increases, with notable gainers including Litong Technology, Jibite, and Zhongtung High-tech, which hit the daily limit [1] - Significant declines were observed in stocks like Kaili Medical, ZTE Corporation, and Nobon Co., with drops of 11.39%, 6.46%, and 6.45% respectively [1] Group 3: Earnings Performance - Among the rated stocks, 292 have reported Q3 earnings, with Optoelectronics achieving a net profit of 24.67 million yuan, a year-on-year increase of 2131.96% [2] - Other notable performers include Light Media and Juyi Technology, with net profit growth rates of 406.78% and 359.88% respectively [2] Group 4: Industry Focus - The electronics sector is the most favored, with 30 stocks including Crystal Optoelectronics and Guocera Materials making the buy rating list [2] - Machinery and automotive sectors also received attention, with 24 and 21 stocks respectively featured in the buy rating list [2]

Market Overview - The cosmetics sector increased by 0.77% on October 29, with Marubi Biological leading the gains [1] - The Shanghai Composite Index closed at 4016.33, up 0.7%, while the Shenzhen Component Index closed at 13691.38, up 1.95% [1] Individual Stock Performance - Marubi Biological (603983) closed at 36.66, up 3.74% with a trading volume of 41,500 shares and a turnover of 150 million yuan [1] - Babi Co. (920123) closed at 18.06, up 3.56% with a trading volume of 23,700 shares and a turnover of 41.72 million yuan [1] - Shanghai Jahwa (600315) closed at 25.46, up 2.74% with a trading volume of 154,500 shares and a turnover of 392 million yuan [1] - Betaini (300957) closed at 45.83, up 0.57% with a trading volume of 33,400 shares and a turnover of 152 million yuan [1] - Other notable performances include Proya (603605) at 76.87, up 0.18%, and Water Sheep Co. (300740) at 22.14, up 0.09% [1] Fund Flow Analysis - The cosmetics sector experienced a net outflow of 89.37 million yuan from institutional investors and 51.47 million yuan from retail investors, while individual investors saw a net inflow of 141 million yuan [2] - The detailed fund flow for individual stocks shows that Shanghai Jahwa had a net outflow of 32.36 million yuan from institutional investors [3] - Marubi Biological had a net inflow of 4.95 million yuan from institutional investors, but a net outflow of 8.77 million yuan from retail investors [3]